Hangzhou Sumgen Biotech Co., Ltd. (hereinafter referred to as “Sumgen” or the “company”) is a biotechnology company dedicated to advancing scientific innovation in the field of antibody based Therapeutics. Established in 2016,the company has rapidly emerged as a key player, leveraging cutting-edge research and development to address critical challenges in treatments for oncology and autoimmune diseases.

Key Features

Innovation and Research Excellence:Sumgen Biotech is at the forefront of innovation, consistently pushing the boundaries of scientific discovery through its state-of-the-art research and development initiatives.

Product Portfolio:Sumgen boasts a diverse portfolio with a robust pipeline of proprietary antibody platforms designed to meet the evolving unmet needs of cancer and autoimmune diseases treatments. Our current pipelines includes several clinical-staged candidates amongst which are SG001, a BLA staged asset targeting late stage solid tumor, SG301 a potential best-in-class monoclonal antibody that is ready for entering pivotal study, and SG1827 a bispecific fusion protein that has demonstrated phenomenal synergistic effects with IO Therapies.

Industrial Presence:Sumgen Biotech operates in the cities of Beijing and Hangzhou with over 120 employees and has built integrated functional headquarters for antibody discovery, cm&c and clinical development, collaborating with industry strategic partners e.g. CSPC Pharmaceutical Group and CNBG, prestige academic institutions e.g. Tsinghua University and Zhejiang University, and healthcare organizations.

Commitment to Sustainability:Sumgen Biotech is committed to environmentally sustainable practices, ensuring that its operations contribute positively to both the scientific community and the planet.

Mission Statement:At Sumgen Biotech, our mission is to “Bring forth High-Quality biological therapeutics to patients throughout the world”, driving progress in life threatening diseases through groundbreaking research, ethical practices, and a commitment to improving global health and well-being.

Corporate Social Responsibility (CSR):Sumgen Biotech actively engages in CSR initiatives, contributing to community development, education, and healthcare access in areas where it operates.

Copyright Rm. 301, F3, Building C, Block 2, No. 688, Bin'an Road, Changhe Zhejiang ICP Filing No. 18039044